Neil W Gibson Insider Trading $TCRR TCR2 THERAPEUTICS INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil W Gibson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil W Gibson. Neil W Gibson is Chief Scientific Officer in Regulus Therapeutics Inc. ($RGLS) and Director in Shattuck Labs, Inc. ($STTK) and Director in TCR2 THERAPEUTICS INC. ($TCRR) and Director in Instil Bio, Inc. ($TIL).
Neil W Gibson in TCR2 THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Neil W Gibson: Director
Holdings: 493,791 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Neil W Gibson in TCR2 THERAPEUTICS INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TIL, RGLS, STTK, TCRR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.94 | 648 | 5,145 | 0 | 648 to 0 (-100.00 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 7.41 | 3,140 | 23,267 | 648 | 3.8 K to 648 (-82.89 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.83 | 3,120 | 21,310 | 3,788 | 6.9 K to 3.8 K (-45.17 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.49 | 3,009 | 19,528 | 6,908 | 9.9 K to 6.9 K (-30.34 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.60 | 17,723 | 117,043 | 9,917 | 27.6 K to 9.9 K (-64.12 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | S | 6.52 | 52,000 | 338,894 | 27,640 | 79.6 K to 27.6 K (-65.29 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 217,974 | 0 | 79,640 | 297.6 K to 79.6 K (-73.24 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 196,177 | 0 | 297,614 | 493.8 K to 297.6 K (-39.73 %) |
| Mar 27 2020 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Sell | J | 0.00 | 212,560 | 0 | 493,791 | 706.4 K to 493.8 K (-30.09 %) |
| Dec 20 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 16.10 | 5,000 | 80,500 | 5,000 | |
| Apr 12 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | A | 16.11 | 6,270 | 101,010 | 6,270 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | C | 0.00 | 4,375,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Buy | C | 0.00 | 706,351 | 0 | 706,351 | 0 to 706.4 K |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Option Exercise | C | 0.00 | 4,375,000 | 0 | 0 | |
| Feb 21 2019 | TCRR | TCR2 THERAPEUTICS ... | Gibson Neil W | Director | Buy | C | 0.00 | 706,351 | 0 | 706,351 | 0 to 706.4 K |
Page: 1